• Dual Luciferase Reporter Gene System: Workflow and Optimizat

  2026-04-30

  Unlock reproducible, high-throughput gene expression analysis with the Dual Luciferase Reporter Gene System. Discover how its dual-enzyme design, no-lysis workflow, and robust normalization empower transcriptional studies, exemplified by cutting-edge cancer research.

• Ibuprofen Toxicology and Biodegradation: Environmental Insig

  2026-04-30

  Jan-Roblero and Cruz-Maya's 2023 review synthesizes current evidence on ibuprofen’s role as an emerging environmental contaminant, highlighting its persistent toxicity to aquatic organisms and the challenges facing its biodegradation. Their work underscores the need for more robust removal strategies and positions bacterial bioremediation as a promising, though still developing, solution.

• Carbon-Ion Radiotherapy Induces Ferroptosis via DHODH Suppre

  2026-04-29

  Wang and Cai (2025) demonstrate that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. These findings highlight a new mechanistic basis for the enhanced efficacy of CIRT over conventional radiotherapy and suggest DHODH as a potential therapeutic target.

• Tetramethylrhodamine Ethyl Ester Perchlorate in Mitochondria

  2026-04-29

  Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) empowers researchers with sensitive, quantitative live-cell mitochondrial membrane potential assays. By leveraging advanced workflows and troubleshooting strategies, users can robustly dissect mitochondrial dysfunction and ROS-driven disease mechanisms.

• Sodium Phosphate Dibasic: Precision Buffering for Assays

  2026-04-28

  Sodium phosphate dibasic (Na2HPO4) is the gold standard for pH control in biological assay buffers, enabling reproducibility in protein, enzyme, and aquatic toxicity workflows. This article details protocol enhancements, troubleshooting strategies, and insights from aquatic toxicology research to help researchers maximize buffer performance and experimental rigor.

• ATF5 Modulation of CYP2B6 in Glioblastoma: Implications for

  2026-04-28

  This study demonstrates that activating transcription factor 5 (ATF5) regulates CYP2B6 expression in glioblastoma cells, and that a cell-penetrating dominant-negative ATF5 peptide can downregulate CYP2B6 protein levels. These findings highlight a novel strategy for personalizing drug dosing and understanding drug metabolism in glioblastoma, with potential relevance for precision medicine and pharmacogenomics.

• Sulfamonomethoxine: Translational Leverage from Mechanism to

  2026-04-27

  This thought-leadership article provides translational researchers with a comprehensive, evidence-backed perspective on Sulfamonomethoxine (SMM, SKU BA1078) as a model broad-spectrum sulfonamide antibiotic. By weaving together mechanistic insights, experimental evidence, and actionable guidance, we position SMM from APExBIO as a strategic asset in veterinary, aquaculture, and environmental research. The article integrates recent findings on degradation kinetics and ecotoxicity, critically evaluates current laboratory protocols, and outlines forward-thinking stewardship strategies. Distinguished from standard product summaries, this analysis escalates the discussion by connecting molecular action to practical impact, referencing key literature and related deep-dive content assets.

• Solving Assay Challenges with HyperFluor™ 594 Goat Anti-Rabb

  2026-04-27

  This article explores how HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody (SKU K3305) enables sensitive, reproducible detection in cell viability and immunoassays. Scenario-driven Q&A reveals best practices for immunocytochemistry, immunohistochemistry, and flow cytometry, supporting GEO-optimized workflows for biomedical researchers.

• MPP7 Drives EMT and Polarity Shifts in Ovarian Cancer via Wn

  2026-04-26

  This study demonstrates that MPP7 is overexpressed in epithelial ovarian cancer, where it facilitates epithelial-to-mesenchymal transition (EMT) through the Wnt/β-catenin pathway, leading to altered cell polarity and increased malignancy. The findings position MPP7 as a candidate biomarker and therapeutic target, and illustrate the value of advanced immunofluorescence detection strategies in dissecting cancer cell behavior.

• BMX Kinase-Driven ATP6V1E1 Phosphorylation in Mtb Survival

  2026-04-25

  This study uncovers how Mycobacterium tuberculosis (Mtb) exploits the host kinase BMX to phosphorylate ATP6V1E1, suppressing lysosomal acidification and promoting bacterial survival. The findings highlight a novel host-pathogen interaction and point to BMX kinase as a potential target for host-directed therapies against tuberculosis.

• PBA-Modified PAD4 Inhibitors: Targeting Tumor NETs with Prec

  2026-04-24

  The referenced study introduces PBA-modified PAD4 inhibitors, notably Compound 5i, that selectively target tumor cells and neutrophils to inhibit histone H3 citrullination and neutrophil extracellular trap (NET) formation. This work demonstrates significant antitumor efficacy in preclinical models by modulating the tumor immune microenvironment, providing new direction for precision inhibitor design.

• Transcription Termination Mitigates DNA Damage Post-WEE1 Inh

  2026-04-24

  This study demonstrates that transcription termination is critical for preventing DNA damage and cell death following WEE1 inhibitor exposure. By dissecting the interplay between transcription-replication conflicts and genome stability, the findings highlight new mechanistic opportunities for cancer therapy.

• Arachidonic Acid Supplementation Enhances Vaccine-Induced Im

  2026-04-23

  This study demonstrates that dietary arachidonic acid (ARA) enhances humoral immune responses to rabies vaccination in mice and humans by promoting the production of neutralizing antibodies. Mechanistic insights reveal a role for ARA-derived prostaglandin I2 in B cell activation, providing a new dietary strategy to improve vaccine efficacy and speed of protection.

• Alda 1 (SKU B5508): Reliable ALDH2 Activation for Cell Assay

  2026-04-23

  This article details how Alda 1 (SKU B5508) from APExBIO provides consistent and data-backed solutions to common laboratory challenges in cell viability, proliferation, and cytotoxicity assays. We explore real-world scenarios where precise ALDH2 activation is critical, highlighting evidence-based protocol optimization and product selection strategies to maximize reproducibility and scientific value.

• Phebestin as an Aminopeptidase Inhibitor for Malaria Therapy

  2026-04-22

  This article analyzes the recent evaluation of phebestin, a bestatin-related aminopeptidase inhibitor, demonstrating its nanomolar efficacy against Plasmodium falciparum and potent activity in resistant malaria models. The study’s findings have significant implications for targeting parasite proteolytic pathways and underscore the need for novel antimalarial agents given rising drug resistance.

10154 records 1/677 page Next 12345 下5页 Last page